AtaCor Medical
PrivateLast Round
Financing
Oct 6, 2025
Est. Valuation
$80M
Total Funding Raised
$61.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AtaCor Medical is a medical device company that develops extravascular cardiac pacing and defibrillation lead systems designed to provide alternatives to traditional transvenous devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AtaCor Medical Comparables
Compare AtaCor Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NewPace | 84% | |
| Medtronic | 78% | |
| Cortex, Inc. | 77% |
AtaCor Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Financing | Oct 6, 2025 | ||||
| Series C | Apr 24, 2024 | ||||
| Series B | Apr 28, 2020 | ||||
| Series A | Sep 18, 2018 |
Key People
Founding team and executive leadership
AtaCor Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BayMed Venture Partners | Series C, Financing |
| CHV | Series C, Series B |
| Arboretum Ventures | Financing, Series C |
| Hatteras Venture Partners | Series B, Series C, Financing |
| aMoon | Series B, Series A |
| Longview Partners | Series B |
| Catalyst Health Ventures | Series B, Series C, Financing |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Partnering with Abbott on investigational extravascular ICD system.
- Oct 6, 2025
$75M round raised
AtaCor Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AtaCor Medical's valuation, stock price, and market status.
Is AtaCor Medical a public or private company?
AtaCor Medical is a private company.
What is the current stock price of AtaCor Medical?
AtaCor Medical is a private company with no public stock price. No recent secondary market data is available.
How much is AtaCor Medical worth (valuation)?
Valuation information for AtaCor Medical is not publicly available.
Can I buy AtaCor Medical stock?
AtaCor Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AtaCor Medical's last funding round?
AtaCor Medical's most recent funding round was Growth Equity on October 6, 2025.
Who are the main investors in AtaCor Medical?
Key investors in AtaCor Medical include CHV, Arboretum Ventures, aMoon, Longview Partners, Broadview Ventures.
Will AtaCor Medical IPO soon?
No public IPO plans have been announced for AtaCor Medical.
How can I track AtaCor Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AtaCor Medical's secondary market activity and sign up for updates.